[1]Patent:US2015/191473,2015,A1.Locationinpatent:Paragraph0232
[2]Patent:WO2016/44666,2016,A1.Locationinpatent:Paragraph0346;0348
[3]Patent:WO2019/37861,2019,A1.Locationinpatent:Page/Pagecolumn113;114
116312-69-7
1803582-12-8
1803593-29-4
1909287-84-8
2126160-11-8
2138297-43-3
17102-64-6 | Trans,trans-2,4-hexadien-1-ol | AA003BY8 | MFCD00002925
42177-25-3 | (R)-1-(Naphthalen-1-yl)ethanol | AA003C3F | MFCD00077830
730980-59-3 | (R)-Chroman-4-ylamine hydrochloride | AA003C8C | MFCD08457629
110529-22-1 | (S)-(+)-2-[Hydroxy(diphenyl)methyl]-1-methylpyrrolidine | AA003CDF | MFCD00145245
42538-31-8 | (S)-3-Aminopiperidin-2-one hydrochloride | AA003CIZ | MFCD09259964
1046786-08-6 | [(Oxido)phenyl(trifluoromethyl)-lambda4-sulfanylidene]dimethylammonium tetrafluoroborate | AA003CNA | MFCD12545962
39512-50-0 | 1-(2-Chlorophenyl)piperazine | AA003CR8 | MFCD00040727
880362-05-0 | 1-(3-Methylpyridin-2-yl)-1,4-diazepane | AA003CUT | MFCD08061111
38220-75-6 | 1-(5-Bromo-1-benzofuran-2-yl)ethanone | AA003CYE | MFCD00276737
883547-73-7 | (1-(Trifluoromethyl)cyclopropyl)benzene | AA003D1T | MFCD08059543